Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The Food and Drug Administration approved Adamas Pharmaceuticals' drug Gocovri to treat dyskinesia, a side effect of a medication prescribed to most Parkinson's disease patients, reports Reuters.
Former Schering-Plough CEO Fred Hassan told CNBC that the "worst solution" to high drug prices is political interference.
The Food and Drug Administration will implement a plan to streamline facility inspection and evaluation processes, which are conducted through the agency's Center for Drug Evaluation and Research and Office of Regulatory Affairs, according to Regulatory Focus.
Here are six articles published by Becker's Hospital Review in the last week, highlighting Walmart's patent for a floating warehouse, one drugmaker's 430 percent price hike and more.
The Food and Drug Administration on Monday approved Solco Healthcare's duloxetine delayed-release capsules.
Centurion Labs recalled its Ninjacof and Ninjacof A cold medicine over potential bacterial contamination.
At the amyotrophic lateral sclerosis clinic at Richmond, Va.-based VCU Medical Center, patient access to the first FDA-approved ALS treatment in 20 years remains limited by restricted insurance coverage and the sheer cost of the drug, according to the Richmond…
Aeroflow Healthcare was named to the Inc. 5000's list of fastest growing companies in 2017.
US Bioservices Corp., a specialty pharmacy unit of AmerisourceBergen, agreed to pay $13.4 million to settle allegations that it pushed patients to refill prescriptions for Novartis AG's iron overload drug, Exjade, in exchange for kickbacks, according to Reuters.
The Food and Drug Administration on Aug. 18 released draft guidance outlining ways to help organizations comply with drug distribution security provisions, according to Regulatory Focus.